CSBR Financials 07/16/2014 00:25:20 Champions Onc
Post# of 13
Champions Oncology, Inc.
Period Ending Apr 30, 2013 Apr 30, 2012 Apr 30, 2011 Apr 30, 2010
Total Revenue 8,323 7,149 6,882 4,893
Cost of Revenue 5,328 4,899 3,511 1,915
Gross Profit 2,995 2,250 3,371 2,978
Operating Expenses
Research and Development 1,920 2,937 2,910 2,622
Sales, General and Admin. 7,296 8,378 5,696 3,284
Non-Recurring Items - - - -
Other - - - -
Operating Income (6,221) (9,065) (5,235) (2,928)
Income From Continuing Operations
Add'l Income/Expense Items (99) 402 1,444 5
Earnings Before Interest and Tax (6,320) (8,663) (3,791) (2,923)
Interest Expense - - - -
Earnings Before Tax (6,320) (8,663) (3,791) (2,923)
Income Tax 10 (2) 11 -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (6,330) (8,661) (3,802) (2,923)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (6,330) (8,661) (3,802) (2,923)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (6,330) (8,661) (3,802) (2,923)